Saudi Arabia Continuous Glucose Monitoring Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Application (Diabetic Patients, Critical Patients), And By End User Industry (Hospitals, Diagnostic Centers and Clinics, Home care) - Forecasts From 2023 To 2028

The Saudi Arabia Continuous Glucose Monitoring Market Size:

Saudi Arabia Continuous Glucose Monitoring Market is expected to witness robust growth over the forecast period.

Continuous glucose monitoring (CGM), also referred to as continuous glucose monitoring, automatically tracks blood glucose levels throughout the day. Making more educated choices about maintaining daily medication use, a healthy diet, and physical activity can be aided with real-time glucose monitoring. A small sensor used in CGM is implanted beneath the skin, often on the arm or abdomen. The sensor picks up interstitial glucose, which is present in the intercellular fluid. The sensor examines the glucose level every few minutes, and wireless data transmission sends the results to a monitor. Moreover, the closed-loop bionic/artificial pancreas has been given a blueprint because of CGMS-based technologies. Thus, businesses that manufacture glucose monitoring devices concentrate largely on creating novel and cutting-edge CGMS. It has several applications for healthcare settings (hospital ICUs, diagnostic centers, and clinics), for all age groups, and geographical locations.

Saudi Arabia Continuous Glucose Monitoring Market Overview & Scope

The Saudi Arabia continuous glucose monitoring market is segmented by:

• Application: The diabetic segment of the continuous glucose monitoring (CGM) market in Saudi Arabia is the fastest-growing application base. This is mainly due to the high prevalence of diabetes in the country, which ranks among the top globally. Diabetes cases are growing with lifestyle changes, the increase of obesity, and the genetic factor, leading to a strong need for continuous glucose monitoring devices to have better control of the disease. Besides, the government's moves under Vision 2030 to raise the use of digital health, the patient's awareness of self-monitoring, and the glucose level being available in real-time are also increasing the demand further.
• Component: Sensors form the essential and fastest-growing part of continuous glucose monitoring (CGM) systems. As sensors must be changed quite often (usually every 7–14 days), they bring in repeat sales that make up the core of the CGM ecosystem. A major part of their acceptance is the technological progress leading to new biocompatible materials, better precision, longer usage time, and less invasive designs. The combination of sensors with wireless communication and AI-based analytics also makes patients more dependent on them.
• End-User Industry: The home care market is the quickest expanding segment, where demand for remote patient monitoring (RPM) and personalized diabetes management at home are the main growth drivers. There is a growing trend among patients to use portable and wearable CGM devices, as they offer continuous data, easy accessibility, and compatibility with smartphones and telehealth platforms. The initiative of the Saudi government for digital health ecosystems and the capital flow in telemedicine have together made it possible for patients to oversee their conditions at home.

Top Trends Shaping the Saudi Arabia Continuous Glucose Monitoring Market

1. The increasing prevalence of diabetes is expected to drive the market for CGM in Saudi Arabia.
   The primary risk factors for diabetes include obesity, particularly central obesity, and increased visceral fat from physical inactivity, as well as the eating of high-calorie, high-fat, and high-sugar meals. The most prevalent work culture in the nation, which promotes eating fast food with little to no exercise and sitting still for extended periods, is a major cause of diabetes in people of working age.

Saudi Arabia Continuous Glucose Monitoring Market Growth Drivers vs. Challenges

Drivers:

• Growing awareness of monitoring devices to surge the growth: The frequency of checking blood sugar levels is determined by the kind of diabetes each patient has, which varies. In Saudi Arabia, where self-monitoring of blood glucose levels has become much more popular, the market for monitoring devices is anticipated to rise rapidly throughout the projected period. The modern CGM systems eliminate all finger pricking for blood glucose monitoring. It provides a more accurate depiction of blood glucose patterns and tendencies than is possible with traditional regular testing of glucose levels at predetermined intervals.
• Developments in CGM Device Technology: Patient acceptance of continuous glucose monitoring (CGM) systems has been boosted with the development of various features, including the longevity of the sensor, minimally invasive insertion, better accuracy, and wireless connectivity. The combined use of CGM tools with insulin pumps, mobile applications, and cloud-based platforms enables users to have comprehensive diabetes management solutions. These breakthroughs enhance the user experience, lower pain levels from finger-prick methods, and foster adherence to treatment over time, which is the main reason why CGM is becoming popular with patients from Saudi Arabia.

Challenges:

• Adoption and Awareness Are Low in Rural Areas: Although urban areas such as Riyadh, Jeddah, and Dammam are experiencing increasing usage of CGM devices, the adoption of advanced monitoring solutions in rural and semi-urban areas is still quite low. Consequently, those living in these locations continue to use the old method of finger pricking for measuring blood glucose levels because of the high cost of the device, the shortage of information, and the limited number of modern healthcare facilities in their areas. Such disparity in knowledge is impeding market penetration that is spread across towns and cities.

Saudi Arabia Continuous Glucose Monitoring Market Competitive Landscape

The market is fragmented, with many notable players, including Sanofi S. A, Johnson & Johnson, Abbott Laboratories, Medtronic plc, Dexcom, Inc., Roche Diabetes Care, Inc., Insulet Corporation, Ypsomed AG, Novo Nordisk A/S, and Bayer Saudi Arabia LLC.

• Collaboration: In January 2024, King Abdullah University of Science and Technology collaborated with Saudi health tech company Amplifai Health to create a cutting-edge diabetes detection system. Through an upcoming clinical trial, this initiative will first target the detection and management of diabetic foot complications by combining HyplexTM hyperspectral imaging technology with Amplifai Health's artificial intelligence capabilities.

Saudi Arabia Continuous Glucose Monitoring Market Segmentation:

• By Application
  • Diabetes Patients
  • Critical Patients
• By Component
  • Sensors
  • Transmitters
  • Receivers/Monitors
• By End-User Industry
  • Hospitals
  • Diagnostic Centers & Clinics
  • Home Care

Sanofi S. A

Johnson & Johnson

Abbott Laboratories

Medtronic plc

Dexcom, Inc.

Roche Diabetes Care, Inc.

Insulet Corporation

Ypsomed AG

Novo Nordisk A/S

Bayer Saudi Arabia LLC